晚期前列腺癌的即时治疗与延迟治疗：医学研究委员会试验的初步结果。医学研究委员会前列腺癌工作组调查员小组 - Suppr

Suppr

超能文献

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.

作者信息

Walsh P C

出版信息

J Urol. 1997 Oct;158(4):1623-4.

PMID:9302187

Abstract

摘要

相似文献

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.晚期前列腺癌的即时治疗与延迟治疗：医学研究委员会试验的初步结果。医学研究委员会前列腺癌工作组调查员小组

J Urol. 1997 Oct;158(4):1623-4.

Immediate versus deferred hormonal treatment for patients with prostate cancer who are not suitable for curative local treatment: results of the randomized trial SAKK 08/88.对不适合根治性局部治疗的前列腺癌患者采用即刻与延迟激素治疗：随机试验SAKK 08/88的结果

J Urol. 2005 Sep;174(3):929. doi: 10.1097/01.ju.0000171900.48158.20.

The case for no initial treatment of localized prostate cancer.局限性前列腺癌不进行初始治疗的理由。

Urol Clin North Am. 1990 Nov;17(4):827-34.

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.晚期前列腺癌的即刻治疗与延迟治疗：医学研究委员会试验的初步结果。医学研究委员会前列腺癌工作组研究人员小组

Br J Urol. 1997 Feb;79(2):235-46. doi: 10.1046/j.1464-410x.1997.d01-6840.x.

Local-regional prostate cancer.局部区域性前列腺癌

Urol Oncol. 2008 Sep-Oct;26(5):516-21. doi: 10.1016/j.urolonc.2008.03.007.

A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.一项比较根治性前列腺切除术加内分泌治疗与外照射放疗加内分泌治疗对局部晚期前列腺癌疗效的随机试验：中位随访102个月的结果

Jpn J Clin Oncol. 2006 Dec;36(12):789-93. doi: 10.1093/jjco/hyl115. Epub 2006 Nov 2.

Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891).使用前列腺特异性抗原（PSA）指导不适合局部根治性治疗的T0-4 N0-2 M0前列腺癌患者雄激素剥夺治疗的时机（欧洲癌症研究与治疗组织30891）

Eur Urol. 2008 May;53(5):941-9. doi: 10.1016/j.eururo.2007.12.032. Epub 2007 Dec 27.

Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891.对于不适合进行根治性局部治疗的前列腺癌患者，立即或延迟雄激素剥夺治疗：欧洲癌症研究与治疗组织（EORTC）试验30891

J Clin Oncol. 2006 Apr 20;24(12):1868-76. doi: 10.1200/JCO.2005.04.7423.

Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.冰岛前列腺腺癌：一项基于人群的研究，涉及1983年至1987年间确诊的男性患者的分期、Gleason分级、治疗及长期生存情况。

Scand J Urol Nephrol. 2006;40(4):265-71. doi: 10.1080/00365590600750110.

Deferred treatment of locally advanced nonmetastatic prostate cancer: a long-term followup.

J Urol. 1999 Feb;161(2):505-8.

引用本文的文献

Multiple roles of circular RNAs in prostate cancer: from the biological basis to potential clinical applications.环状RNA在前列腺癌中的多重作用：从生物学基础到潜在临床应用

Eur J Med Res. 2025 Feb 27;30(1):140. doi: 10.1186/s40001-025-02382-0.

Secondary Osteoporosis and Metabolic Bone Diseases.继发性骨质疏松症和代谢性骨病

J Clin Med. 2022 Apr 24;11(9):2382. doi: 10.3390/jcm11092382.

Circular RNAs in prostate cancer: Biogenesis,biological functions, and clinical significance.前列腺癌中的环状RNA：生物发生、生物学功能及临床意义

Mol Ther Nucleic Acids. 2021 Oct 20;26:1130-1147. doi: 10.1016/j.omtn.2021.10.017. eCollection 2021 Dec 3.

Risk of dementia and Parkinson's disease in patients treated with androgen deprivation therapy using gonadotropin-releasing hormone agonist for prostate cancer: A nationwide population-based cohort study.使用促性腺激素释放激素激动剂进行雄激素剥夺治疗的前列腺癌患者患痴呆症和帕金森病的风险：一项基于全国人口的队列研究。

PLoS One. 2020 Dec 30;15(12):e0244660. doi: 10.1371/journal.pone.0244660. eCollection 2020.

Clinical and Novel Biomarkers in the Management of Prostate Cancer.前列腺癌诊治的临床与新型生物标志物

Curr Treat Options Oncol. 2018 Feb 8;19(2):8. doi: 10.1007/s11864-018-0527-z.

Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer.恩杂鲁胺作为第二代抗雄激素药物用于治疗晚期前列腺癌。

Drug Des Devel Ther. 2013 Aug 27;7:875-81. doi: 10.2147/DDDT.S45703. eCollection 2013.

Androgen-deprivation therapy and risk for biliary disease in men with prostate cancer.雄激素剥夺治疗与前列腺癌男性患者胆道疾病风险的相关性。

Eur Urol. 2014 Mar;65(3):642-9. doi: 10.1016/j.eururo.2013.02.003. Epub 2013 Feb 12.

Overcoming drug resistance and treating advanced prostate cancer.克服耐药性并治疗晚期前列腺癌。

Curr Drug Targets. 2012 Sep 1;13(10):1308-23. doi: 10.2174/138945012802429615.

Prospective study of changes in the metabolomic profiles of men during their first three months of androgen deprivation therapy for prostate cancer.前瞻性研究前列腺癌患者雄激素剥夺治疗头 3 个月期间男性代谢组学特征的变化。

Clin Cancer Res. 2012 Jul 1;18(13):3677-85. doi: 10.1158/1078-0432.CCR-11-3209. Epub 2012 May 15.

Gonadotropin-releasing hormone agonists and the risks of type 2 diabetes and cardiovascular disease in men with prostate cancer.促性腺激素释放激素激动剂与前列腺癌男性 2 型糖尿病和心血管疾病风险

Drugs. 2011 Feb 12;71(3):255-61. doi: 10.2165/11588930-000000000-00000.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验